Report Details

Nucleic Acid Therapeutic Market, Global Outlook and Forecast 2023-2029

ID : PRR-421268
Date : 2023-11-23
Pages : 146
Industry : Pharmaceutical and Healthcare

This research report provides a comprehensive analysis of the Nucleic Acid Therapeutic market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nucleic Acid Therapeutic market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nucleic Acid Therapeutic, challenges faced by the industry, and potential opportunities for market players.
The global Nucleic Acid Therapeutic market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nucleic Acid Therapeutic market presents opportunities for various stakeholders, including Neuromuscular Diseases, hATTR. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nucleic Acid Therapeutic market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nucleic Acid Therapeutic market was valued at US$ 60320 million in 2022 and is projected to reach US$ 14820 million by 2029, at a CAGR of 3.9% during the forecast period.
The Nucleic Acid-Based Therapeutics Drug Market is driven by the promising potential of nucleic acid-based therapies in treating various genetic and acquired diseases, including genetic disorders, cancer, and infectious diseases. These innovative drugs utilize nucleic acids, such as DNA or RNA, to modify or regulate gene expression, correct genetic mutations, or target specific disease-associated genes. As the understanding of genomics and molecular biology advances, and personalized medicine gains traction, the demand for nucleic acid-based therapeutics continues to grow. Innovations in drug development, delivery systems, and gene editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address delivery and stability issues, ensure long-term safety and efficacy, and navigate regulatory complexities and patient acceptance. Overcoming technical and scientific hurdles, optimizing drug delivery methods, and addressing concerns about off-target effects are ongoing challenges. Additionally, the market faces competition from conventional therapies and the need for continuous research and development to unlock the full therapeutic potential of nucleic acid-based drugs. Striking a balance between providing safe, effective, and accessible nucleic acid-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Nucleic Acid-Based Therapeutics Drug Market.
Key Features:
The research report on the Nucleic Acid Therapeutic market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nucleic Acid Therapeutic market.
Market Overview: The report provides a comprehensive overview of the Nucleic Acid Therapeutic market, including its definition, historical development, and current market size. It covers market segmentation by Type e.g., Antisense Oligonucleotides ASO, siRNA, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nucleic Acid Therapeutic market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nucleic Acid Therapeutic markets trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nucleic Acid Therapeutic market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nucleic Acid Therapeutic market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nucleic Acid Therapeutic market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nucleic Acid Therapeutic market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nucleic Acid Therapeutic, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nucleic Acid Therapeutic market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nucleic Acid Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antisense Oligonucleotides ASO
siRNA
mRNA
Market segment by Application
Neuromuscular Diseases
hATTR
COVID-19
Other
Global Nucleic Acid Therapeutic Market Segment Percentages, By Region and Country, 2022 %
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nucleic Acid Therapeutic, market overview.
Chapter 2: Global Nucleic Acid Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Nucleic Acid Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nucleic Acid Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid Therapeutic Overall Market Size
2.1 Global Nucleic Acid Therapeutic Market Size: 2022 VS 2029
2.2 Global Nucleic Acid Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nucleic Acid Therapeutic Players in Global Market
3.2 Top Global Nucleic Acid Therapeutic Companies Ranked by Revenue
3.3 Global Nucleic Acid Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Nucleic Acid Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nucleic Acid Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Nucleic Acid Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nucleic Acid Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Antisense Oligonucleotides ASO
4.1.3 siRNA
4.1.4 mRNA
4.2 By Type - Global Nucleic Acid Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Nucleic Acid Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Nucleic Acid Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nucleic Acid Therapeutic Market Size, 2022 & 2029
5.1.2 Neuromuscular Diseases
5.1.3 hATTR
5.1.4 COVID-19
5.1.5 Other
5.2 By Application - Global Nucleic Acid Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Nucleic Acid Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Nucleic Acid Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Nucleic Acid Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global Nucleic Acid Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Nucleic Acid Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Nucleic Acid Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Nucleic Acid Therapeutic Revenue, 2018-2029
6.3.2 US Nucleic Acid Therapeutic Market Size, 2018-2029
6.3.3 Canada Nucleic Acid Therapeutic Market Size, 2018-2029
6.3.4 Mexico Nucleic Acid Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Nucleic Acid Therapeutic Revenue, 2018-2029
6.4.2 Germany Nucleic Acid Therapeutic Market Size, 2018-2029
6.4.3 France Nucleic Acid Therapeutic Market Size, 2018-2029
6.4.4 U.K. Nucleic Acid Therapeutic Market Size, 2018-2029
6.4.5 Italy Nucleic Acid Therapeutic Market Size, 2018-2029
6.4.6 Russia Nucleic Acid Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Nucleic Acid Therapeutic Market Size, 2018-2029
6.4.8 Benelux Nucleic Acid Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Nucleic Acid Therapeutic Revenue, 2018-2029
6.5.2 China Nucleic Acid Therapeutic Market Size, 2018-2029
6.5.3 Japan Nucleic Acid Therapeutic Market Size, 2018-2029
6.5.4 South Korea Nucleic Acid Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Nucleic Acid Therapeutic Market Size, 2018-2029
6.5.6 India Nucleic Acid Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Nucleic Acid Therapeutic Revenue, 2018-2029
6.6.2 Brazil Nucleic Acid Therapeutic Market Size, 2018-2029
6.6.3 Argentina Nucleic Acid Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nucleic Acid Therapeutic Revenue, 2018-2029
6.7.2 Turkey Nucleic Acid Therapeutic Market Size, 2018-2029
6.7.3 Israel Nucleic Acid Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Nucleic Acid Therapeutic Market Size, 2018-2029
6.7.5 UAE Nucleic Acid Therapeutic Market Size, 2018-2029
7 Nucleic Acid Therapeutic Companies Profiles
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Company Summary
7.1.2 Sarepta Therapeutics Business Overview
7.1.3 Sarepta Therapeutics Nucleic Acid Therapeutic Major Product Offerings
7.1.4 Sarepta Therapeutics Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.1.5 Sarepta Therapeutics Key News & Latest Developments
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Company Summary
7.2.2 Ionis Pharmaceuticals Business Overview
7.2.3 Ionis Pharmaceuticals Nucleic Acid Therapeutic Major Product Offerings
7.2.4 Ionis Pharmaceuticals Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.2.5 Ionis Pharmaceuticals Key News & Latest Developments
7.3 Alnylam
7.3.1 Alnylam Company Summary
7.3.2 Alnylam Business Overview
7.3.3 Alnylam Nucleic Acid Therapeutic Major Product Offerings
7.3.4 Alnylam Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.3.5 Alnylam Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Nucleic Acid Therapeutic Major Product Offerings
7.4.4 Biogen Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.4.5 Biogen Key News & Latest Developments
7.5 Nippon Shinyaku
7.5.1 Nippon Shinyaku Company Summary
7.5.2 Nippon Shinyaku Business Overview
7.5.3 Nippon Shinyaku Nucleic Acid Therapeutic Major Product Offerings
7.5.4 Nippon Shinyaku Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.5.5 Nippon Shinyaku Key News & Latest Developments
7.6 Sobi
7.6.1 Sobi Company Summary
7.6.2 Sobi Business Overview
7.6.3 Sobi Nucleic Acid Therapeutic Major Product Offerings
7.6.4 Sobi Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.6.5 Sobi Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Nucleic Acid Therapeutic Major Product Offerings
7.7.4 Novartis Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.7.5 Novartis Key News & Latest Developments
7.8 BioNTech
7.8.1 BioNTech Company Summary
7.8.2 BioNTech Business Overview
7.8.3 BioNTech Nucleic Acid Therapeutic Major Product Offerings
7.8.4 BioNTech Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.8.5 BioNTech Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Nucleic Acid Therapeutic Major Product Offerings
7.9.4 Pfizer Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.9.5 Pfizer Key News & Latest Developments
7.10 Moderna Therapeutics
7.10.1 Moderna Therapeutics Company Summary
7.10.2 Moderna Therapeutics Business Overview
7.10.3 Moderna Therapeutics Nucleic Acid Therapeutic Major Product Offerings
7.10.4 Moderna Therapeutics Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.10.5 Moderna Therapeutics Key News & Latest Developments
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Company Summary
7.11.2 Jazz Pharmaceuticals Business Overview
7.11.3 Jazz Pharmaceuticals Nucleic Acid Therapeutic Major Product Offerings
7.11.4 Jazz Pharmaceuticals Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.11.5 Jazz Pharmaceuticals Key News & Latest Developments
7.12 CureVac
7.12.1 CureVac Company Summary
7.12.2 CureVac Business Overview
7.12.3 CureVac Nucleic Acid Therapeutic Major Product Offerings
7.12.4 CureVac Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.12.5 CureVac Key News & Latest Developments
7.13 Regulus Therapeutics
7.13.1 Regulus Therapeutics Company Summary
7.13.2 Regulus Therapeutics Business Overview
7.13.3 Regulus Therapeutics Nucleic Acid Therapeutic Major Product Offerings
7.13.4 Regulus Therapeutics Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.13.5 Regulus Therapeutics Key News & Latest Developments
7.14 ProQR
7.14.1 ProQR Company Summary
7.14.2 ProQR Business Overview
7.14.3 ProQR Nucleic Acid Therapeutic Major Product Offerings
7.14.4 ProQR Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.14.5 ProQR Key News & Latest Developments
7.15 Secarna
7.15.1 Secarna Company Summary
7.15.2 Secarna Business Overview
7.15.3 Secarna Nucleic Acid Therapeutic Major Product Offerings
7.15.4 Secarna Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.15.5 Secarna Key News & Latest Developments
7.16 MiNA Therapeutics
7.16.1 MiNA Therapeutics Company Summary
7.16.2 MiNA Therapeutics Business Overview
7.16.3 MiNA Therapeutics Nucleic Acid Therapeutic Major Product Offerings
7.16.4 MiNA Therapeutics Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.16.5 MiNA Therapeutics Key News & Latest Developments
7.17 Sylentis
7.17.1 Sylentis Company Summary
7.17.2 Sylentis Business Overview
7.17.3 Sylentis Nucleic Acid Therapeutic Major Product Offerings
7.17.4 Sylentis Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.17.5 Sylentis Key News & Latest Developments
7.18 Arrowhead
7.18.1 Arrowhead Company Summary
7.18.2 Arrowhead Business Overview
7.18.3 Arrowhead Nucleic Acid Therapeutic Major Product Offerings
7.18.4 Arrowhead Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.18.5 Arrowhead Key News & Latest Developments
7.19 Silence Therapeutics
7.19.1 Silence Therapeutics Company Summary
7.19.2 Silence Therapeutics Business Overview
7.19.3 Silence Therapeutics Nucleic Acid Therapeutic Major Product Offerings
7.19.4 Silence Therapeutics Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.19.5 Silence Therapeutics Key News & Latest Developments
7.20 Dicerna
7.20.1 Dicerna Company Summary
7.20.2 Dicerna Business Overview
7.20.3 Dicerna Nucleic Acid Therapeutic Major Product Offerings
7.20.4 Dicerna Nucleic Acid Therapeutic Revenue in Global Market 2018-2023
7.20.5 Dicerna Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Nucleic Acid Therapeutic Market Opportunities & Trends in Global Market
Table 2. Nucleic Acid Therapeutic Market Drivers in Global Market
Table 3. Nucleic Acid Therapeutic Market Restraints in Global Market
Table 4. Key Players of Nucleic Acid Therapeutic in Global Market
Table 5. Top Nucleic Acid Therapeutic Players in Global Market, Ranking by Revenue 2022
Table 6. Global Nucleic Acid Therapeutic Revenue by Companies, US$, Mn, 2018-2023
Table 7. Global Nucleic Acid Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nucleic Acid Therapeutic Product Type
Table 9. List of Global Tier 1 Nucleic Acid Therapeutic Companies, Revenue US$, Mn in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nucleic Acid Therapeutic Companies, Revenue US$, Mn in 2022 and Market Share
Table 11. By Type – Global Nucleic Acid Therapeutic Revenue, US$, Mn, 2022 & 2029
Table 12. By Type - Nucleic Acid Therapeutic Revenue in Global US$, Mn, 2018-2023
Table 13. By Type - Nucleic Acid Therapeutic Revenue in Global US$, Mn, 2024-2029
Table 14. By Application – Global Nucleic Acid Therapeutic Revenue, US$, Mn, 2022 & 2029
Table 15. By Application - Nucleic Acid Therapeutic Revenue in Global US$, Mn, 2018-2023
Table 16. By Application - Nucleic Acid Therapeutic Revenue in Global US$, Mn, 2024-2029
Table 17. By Region – Global Nucleic Acid Therapeutic Revenue, US$, Mn, 2022 & 2029
Table 18. By Region - Global Nucleic Acid Therapeutic Revenue US$, Mn, 2018-2023
Table 19. By Region - Global Nucleic Acid Therapeutic Revenue US$, Mn, 2024-2029
Table 20. By Country - North America Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2023
Table 21. By Country - North America Nucleic Acid Therapeutic Revenue, US$, Mn, 2024-2029
Table 22. By Country - Europe Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2023
Table 23. By Country - Europe Nucleic Acid Therapeutic Revenue, US$, Mn, 2024-2029
Table 24. By Region - Asia Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2023
Table 25. By Region - Asia Nucleic Acid Therapeutic Revenue, US$, Mn, 2024-2029
Table 26. By Country - South America Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2023
Table 27. By Country - South America Nucleic Acid Therapeutic Revenue, US$, Mn, 2024-2029
Table 28. By Country - Middle East & Africa Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2023
Table 29. By Country - Middle East & Africa Nucleic Acid Therapeutic Revenue, US$, Mn, 2024-2029
Table 30. Sarepta Therapeutics Company Summary
Table 31. Sarepta Therapeutics Nucleic Acid Therapeutic Product Offerings
Table 32. Sarepta Therapeutics Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 33. Sarepta Therapeutics Key News & Latest Developments
Table 34. Ionis Pharmaceuticals Company Summary
Table 35. Ionis Pharmaceuticals Nucleic Acid Therapeutic Product Offerings
Table 36. Ionis Pharmaceuticals Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 37. Ionis Pharmaceuticals Key News & Latest Developments
Table 38. Alnylam Company Summary
Table 39. Alnylam Nucleic Acid Therapeutic Product Offerings
Table 40. Alnylam Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 41. Alnylam Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen Nucleic Acid Therapeutic Product Offerings
Table 44. Biogen Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 45. Biogen Key News & Latest Developments
Table 46. Nippon Shinyaku Company Summary
Table 47. Nippon Shinyaku Nucleic Acid Therapeutic Product Offerings
Table 48. Nippon Shinyaku Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 49. Nippon Shinyaku Key News & Latest Developments
Table 50. Sobi Company Summary
Table 51. Sobi Nucleic Acid Therapeutic Product Offerings
Table 52. Sobi Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 53. Sobi Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Nucleic Acid Therapeutic Product Offerings
Table 56. Novartis Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 57. Novartis Key News & Latest Developments
Table 58. BioNTech Company Summary
Table 59. BioNTech Nucleic Acid Therapeutic Product Offerings
Table 60. BioNTech Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 61. BioNTech Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Nucleic Acid Therapeutic Product Offerings
Table 64. Pfizer Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 65. Pfizer Key News & Latest Developments
Table 66. Moderna Therapeutics Company Summary
Table 67. Moderna Therapeutics Nucleic Acid Therapeutic Product Offerings
Table 68. Moderna Therapeutics Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 69. Moderna Therapeutics Key News & Latest Developments
Table 70. Jazz Pharmaceuticals Company Summary
Table 71. Jazz Pharmaceuticals Nucleic Acid Therapeutic Product Offerings
Table 72. Jazz Pharmaceuticals Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 73. Jazz Pharmaceuticals Key News & Latest Developments
Table 74. CureVac Company Summary
Table 75. CureVac Nucleic Acid Therapeutic Product Offerings
Table 76. CureVac Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 77. CureVac Key News & Latest Developments
Table 78. Regulus Therapeutics Company Summary
Table 79. Regulus Therapeutics Nucleic Acid Therapeutic Product Offerings
Table 80. Regulus Therapeutics Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 81. Regulus Therapeutics Key News & Latest Developments
Table 82. ProQR Company Summary
Table 83. ProQR Nucleic Acid Therapeutic Product Offerings
Table 84. ProQR Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 85. ProQR Key News & Latest Developments
Table 86. Secarna Company Summary
Table 87. Secarna Nucleic Acid Therapeutic Product Offerings
Table 88. Secarna Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 89. Secarna Key News & Latest Developments
Table 90. MiNA Therapeutics Company Summary
Table 91. MiNA Therapeutics Nucleic Acid Therapeutic Product Offerings
Table 92. MiNA Therapeutics Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 93. MiNA Therapeutics Key News & Latest Developments
Table 94. Sylentis Company Summary
Table 95. Sylentis Nucleic Acid Therapeutic Product Offerings
Table 96. Sylentis Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 97. Sylentis Key News & Latest Developments
Table 98. Arrowhead Company Summary
Table 99. Arrowhead Nucleic Acid Therapeutic Product Offerings
Table 100. Arrowhead Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 101. Arrowhead Key News & Latest Developments
Table 102. Silence Therapeutics Company Summary
Table 103. Silence Therapeutics Nucleic Acid Therapeutic Product Offerings
Table 104. Silence Therapeutics Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 105. Silence Therapeutics Key News & Latest Developments
Table 106. Dicerna Company Summary
Table 107. Dicerna Nucleic Acid Therapeutic Product Offerings
Table 108. Dicerna Nucleic Acid Therapeutic Revenue US$, Mn & 2018-2023
Table 109. Dicerna Key News & Latest Developments
List of Figures
Figure 1. Nucleic Acid Therapeutic Segment by Type in 2022
Figure 2. Nucleic Acid Therapeutic Segment by Application in 2022
Figure 3. Global Nucleic Acid Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nucleic Acid Therapeutic Market Size: 2022 VS 2029 US$, Mn
Figure 6. Global Nucleic Acid Therapeutic Revenue, 2018-2029 US$, Mn
Figure 7. The Top 3 and 5 Players Market Share by Nucleic Acid Therapeutic Revenue in 2022
Figure 8. By Type - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Nucleic Acid Therapeutic Revenue, US$, Mn, 2022 & 2029
Figure 11. By Type - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Nucleic Acid Therapeutic Revenue, US$, Mn, 2022 & 2029
Figure 13. By Application - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 16. US Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 17. Canada Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 18. Mexico Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 19. By Country - Europe Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 20. Germany Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 21. France Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 22. U.K. Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 23. Italy Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 24. Russia Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 25. Nordic Countries Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 26. Benelux Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 27. By Region - Asia Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 28. China Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 29. Japan Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 30. South Korea Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 31. Southeast Asia Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 32. India Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 33. By Country - South America Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 34. Brazil Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 35. Argentina Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 36. By Country - Middle East & Africa Nucleic Acid Therapeutic Revenue Market Share, 2018-2029
Figure 37. Turkey Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 38. Israel Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 39. Saudi Arabia Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 40. UAE Nucleic Acid Therapeutic Revenue, US$, Mn, 2018-2029
Figure 41. Sarepta Therapeutics Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 42. Ionis Pharmaceuticals Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 43. Alnylam Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 44. Biogen Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 45. Nippon Shinyaku Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 46. Sobi Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 47. Novartis Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 48. BioNTech Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 49. Pfizer Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 50. Moderna Therapeutics Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 51. Jazz Pharmaceuticals Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 52. CureVac Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 53. Regulus Therapeutics Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 54. ProQR Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 55. Secarna Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 56. MiNA Therapeutics Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 57. Sylentis Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 58. Arrowhead Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 59. Silence Therapeutics Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 60. Dicerna Nucleic Acid Therapeutic Revenue Year Over Year Growth US$, Mn & 2018-2023

Choose License Type









  Enquire Before Purchase

Have A Question ?
  Email Us


Custom Research

Still haven't found what you're looking for ?
Speak to our Custom Research Team

  Learn More

Why ProspectResearch Reports

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays



ProspectResearch Reports Logo

What our clients say